Sfoglia per AUTORE
MOIOLA L
Collezione AOU San Luigi di Orbassano

  

Items : 19

Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study. in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2024 Jul;21(4):e00363. doi: 10.1016/j.neurot.2024.e00363. Epub 2024 May 7.
2024
AOU San Luigi di Orbassano

Chisari CG; Aguglia U; Amato MP; Bergamaschi R; Bertolotto A; Bonavita S; Morra VB; Cavalla P; Cocco E; Conte A; Cottone S; De Luca G; Di Sapio A; Filippi M; Gallo A; Gasperini C; Granella F; Lus G; Maimone D; Maniscalco GT; Marfia G; Moiola L; Paolicelli D; Pesci I; Ragonese P; Rovaris M; Salemi G; Solaro C; Totaro R; et alii...

Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab. in Journal of neuroimmunology / J Neuroimmunol. 2023 Sep 15;382:578170. doi: 10.1016/j.jneuroim.2023.578170. Epub 2023 Aug 7.
2023
AOU San Luigi di Orbassano

Sottini A; Quaresima V; Barbaro M; Moiola L; Filippi M; Malentacchi M; Capobianco M; Puthenparampil M; Gallo P; Cocco E; Frau J; Zaffaroni M; Guaschino C; Stampatori C; Mancinelli C; Brambilla L; Clerici VT; Vianello M; Vitetta F; Ferraro D; Rosettani P; Danni MC; Conti M; Grimoldi M; Capra R; Imberti L;

Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Oct;78:104907. doi: 10.1016/j.msard.2023.104907. Epub 2023 Jul 26.
2023
AOU San Luigi di Orbassano

Petracca M; Carotenuto A; Scandurra C; Moccia M; Rosa L; Arena S; Ianniello A; Nozzolillo A; Turrini M; Streito LM; Abbadessa G; Cellerino M; Bucello S; Ferraro E; Mattioli M; Chiodi A; Inglese M; Bonavita S; Clerico M; Cordioli C; Moiola L; Patti F; Lavorgna L; Filippi M; Borriello G; D'Amico E; Pozzilli C; Brescia Morra V; Lanzillo R; et alii...

Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression. in Journal of clinical medicine / J Clin Med. 2023 Mar 13;12(6):2215. doi: 10.3390/jcm12062215.
2023
AOU San Luigi di Orbassano

Scandurra C; Rosa L; Carotenuto A; Moccia M; Arena S; Ianniello A; Nozzolillo A; Turrini M; Streito LM; Abbadessa G; Ferraro E; Mattioli M; Chiodi A; Maldonato NM; Bonavita S; Clerico M; Cordioli C; Moiola L; Patti F; Lavorgna L; Filippi M; Borriello G; D'Amico E; Pozzilli C; Brescia Morra V; Petracca M; Lanzillo R;

Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329657. doi: 10.1136/jnnp-2022-329657.
2022
AOU San Luigi di Orbassano

Landi D; Bovis F; Grimaldi A; Annovazzi PO; Bertolotto A; Bianchi A; Borriello G; Brescia Morra V; Bucello S; Buscarinu MC; Caleri F; Capobianco M; Capra R; Cellerino M; Centonze D; Cerqua R; Chisari CG; Clerico M; Cocco E; Cola G; Cordioli C; Curti E; d'Ambrosio A; D'Amico E; De Luca G; Di Filippo M; Di Lemme S; Fantozzi R; Ferraro D; et alii...

Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2022 Jan 19;9(2):e1141. doi: 10.1212/NXI.0000000000001141. Print 2
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Trojano M; Amato MP; Filippi M; Battaglia MA; Comi G; Tedeschi G; Ponzio M; Mosconi P; Lepore V; Ferraro D; Moiola L; Petracca M; Malucchi S; Toscano S; Totaro R; Brambilla L; Vianello M; Ragonese P; Granella F; Maniscalco GT; Montepietra S; Cavalla P; Lugaresi A; De Luca G; Lus G; Pesci I; Sola P; Brescia Morra V; Capobianco M; et alii...

A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2022 Jul;63:103909. doi: 10.1016/j.msard.2022.103909. Epub 2022 May 25.
2022
AOU San Luigi di Orbassano

Ponzano M; Schiavetti I; Bovis F; Landi D; Carmisciano L; De Rossi N; Cordioli C; Moiola L; Radaelli M; Immovilli P; Capobianco M; Bragadin MM; Cocco E; Scandellari C; Cavalla P; Pesci I; Confalonieri P; Perini P; Bergamaschi R; Inglese M; Petracca M; Trojano M; Tedeschi G; Comi G; Battaglia MA; Patti F; Fragoso YD; Sen S; Siva A; et alii...

Vaccinations in patients with multiple sclerosis: A Delphi consensus statement. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2021 Mar;27(3):347-359. doi: 10.1177/1352458520952310. Epub 2020 Sep 17.
2021
AOU San Luigi di Orbassano

Scarpazza C; Puoti M; Prosperini L; Origoni M; Meroni L; Gerevini S; Galli M; Franzetti F; Comi G; Fasolo MM; Cinque P; Capra R; Capobianco M; Benatti SV; Barcella V; Riva A; Tortorella C; Zaffaroni M; Moiola L;

The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2021 Mar;27(3):331-346. doi: 10.1177/1352458520952311. Epub 2020 Sep 17.
2021
AOU San Luigi di Orbassano

Moiola L; Barcella V; Benatti S; Capobianco M; Capra R; Cinque P; Comi G; Fasolo MM; Franzetti F; Galli M; Gerevini S; Meroni L; Origoni M; Prosperini L; Puoti M; Scarpazza C; Tortorella C; Zaffaroni M; Riva A; Moiola L; Barcella V; Benatti S; Capobianco M; Capra R; Cinque P; Comi G; Fasolo MM; Franzetti F; Galli M; et alii...

Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis. in Neurology / Neurology. 2021 Feb 22;96(8):e1215-e1226. doi: 10.1212/WNL.0000000000011461.
2021
AOU San Luigi di Orbassano

Boffa G; Massacesi L; Inglese M; Mariottini A; Capobianco M; Moiola L; Amato MP; Cottone S; Gualandi F; De Gobbi M; Greco R; Scimè R; Frau J; Zimatore GB; Bertolotto A; Comi G; Uccelli A; Signori A; Angelucci E; Innocenti C; Ciceri F; Repice AM; Sormani MP; Saccardi R; Mancardi G;

DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France. in Annals of clinical and translational neurology / Ann Clin Transl Neurol. 2021 Aug;8(8):1738-1744. doi: 10.1002/acn3.51408. Epub 2021 Jul 7.
2021
AOU San Luigi di Orbassano

Sormani MP; Salvetti M; Labauge P; Schiavetti I; Zephir H; Carmisciano L; Bensa C; De Rossi N; Pelletier J; Cordioli C; Vukusic S; Moiola L; Kerschen P; Radaelli M; Théaudin M; Immovilli P; Casez O; Capobianco M; Ciron J; Trojano M; Stankoff B; Créange A; Tedeschi G; Clavelou P; Comi G; Thouvenot E; Battaglia MA; Moreau T; Patti F; et alii...

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. in Annals of neurology / Ann Neurol. 2021 Apr;89(4):780-789. doi: 10.1002/ana.26028. Epub 2021 Feb 9.
2021
AOU San Luigi di Orbassano

Sormani MP; De Rossi N; Schiavetti I; Carmisciano L; Cordioli C; Moiola L; Radaelli M; Immovilli P; Capobianco M; Trojano M; Zaratin P; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M;

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2019 Mar;25(3):399-407. doi: 10.1177/1352458518754364. Epub 2018 Jan 24.
2019
AOU San Luigi di Orbassano

Baroncini D; Zaffaroni M; Moiola L; Lorefice L; Fenu G; Iaffaldano P; Simone M; Fanelli F; Patti F; D'Amico E; Capobianco M; Bertolotto A; Gallo P; Margoni M; Miante S; Milani N; Amato MP; Righini I; Bellantonio P; Scandellari C; Costantino G; Scarpini E; Bergamaschi R; Mallucci G; Comi G; Ghezzi A;

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study. in Journal of neurology / J Neurol. 2018 Dec;265(12):2851-2860. doi: 10.1007/s00415-018-9070-x. Epub 2018 Sep 26.
2018
AOU San Luigi di Orbassano

Prosperini L; Annovazzi P; Boffa L; Buscarinu MC; Gallo A; Matta M; Moiola L; Musu L; Perini P; Avolio C; Barcella V; Bianco A; Farina D; Ferraro E; Pontecorvo S; Granella F; Grimaldi LME; Laroni A; Lus G; Patti F; Pucci E; Pasca M; Sarchielli P;

Corrigendum to "Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?" [J. Neurol. Sci. 378 (2017) 233-237]. in Journal of the neurological sciences / J Neurol Sci. 2017 Sep 15;380:19. doi: 10.1016/j.jns.2017.06.037. Epub 2017 Jul 4.
2017
AOU San Luigi di Orbassano
AOU Novara

Gerevini S; Imberti L; Naldi P; Moiola L; Capobianco M; Lugaresi A; De Rossi N; Mancinelli CR; Prosperini L; Scarpazza C; Capra R;

Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? in Journal of the neurological sciences / J Neurol Sci. 2017 Jul 15;378:233-237. doi: 10.1016/j.jns.2017.05.018. Epub 2017 May 12.
2017
AOU San Luigi di Orbassano
AOU Novara

Gerevini S; Imberti L; Naldi P; Moiola L; Capobianco M; Lugaresi A; De Rossi N; Mancinelli CR; Prosperini L; Scarpazza C; Capra R;

Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study. in Journal of neurology / J Neurol. 2016 Sep;263(9):1727-35. doi: 10.1007/s00415-016-8188-y. Epub 2016 Jun 10.
2016
AOU San Luigi di Orbassano

Moiola L; Annovazzi P; Capobianco M; Patti F; Frau J; Uccelli A; Centonze D; Perini P; Tortorella C; Prosperini L; Lus G; Fuiani A; Falcini M; Martinelli V; Comi G; Ghezzi A;

Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study. in Expert opinion on drug delivery / Expert Opin Drug Deliv. 2016 Jun;13(6):799-805. doi: 10.1517/17425247.2016.1158161. Epub 2016 Mar 12
2016
AOU San Luigi di Orbassano

Paolicelli D; Cocco E; Di Lecce V; Direnzo V; Moiola L; Lanzillo R; Perini P; Malucchi S; Borriello G; Portaccio E; Panetta V; Fenu G; Sangalli F; Cacciaguerra L; Trojano M;

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2014 Feb;35(2):307-16. doi: 10.1007/s10072-013-1616-1. Epub 2013 Dec 29.
2014
AOU San Luigi di Orbassano

Bertolotto A; Capobianco M; Amato MP; Capello E; Capra R; Centonze D; Di Ioia M; Gallo A; Grimaldi L; Imberti L; Lugaresi A; Mancinelli C; Marrosu MG; Moiola L; Montanari E; Romano S; Musu L; Paolicelli D; Patti F; Pozzilli C; Rossi S; Salvetti M; Tedeschi G; Tola MR; Trojano M; Zaffaroni M; Malucchi S; Bertolotto A; Capobianco M; et alii...